A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet.

Source:http://linkedlifedata.com/resource/pubmed/id/22046602

J. Acquir. Immune Defic. Syndr. 2011 Apr 15 56 5 e130-2

Download in:

View as

Triples

General Info

PMID
22046602